[Results of catheter embolization of renal cell carcinoma].
OBJECTIVE
We pointed out the value of catheter embolisation of kidney tumours.


METHODS
We treated 42 patients with kidney tumours. For peripheral embolisation we placed Histoacryl or Ethibloc into the kidney artery via a transfemoral catheter. 33 patients had haematuria. 8 patients were lost for follow up. 26 patients were treated by embolisation alone and 8 patients were treated before nephrectomy.


RESULTS
Haematuria was stopped in 98% and never reoccurred. The intraoperative blood-loss was 600 ml on average. 55% of patients treated by embolisation alone died within the first year. 51% of patients suffered from a slight postinfarction syndrome. One patient died of sepsis and one had pulmonary insufficiency due to AV shunt and pulmonary embolism.


CONCLUSIONS
Peripheral embolisation of kidney tumours can be used successfully and is minimal invasive, in case of haematuria and pain. The perioperative risk is reduced due to limited blood loss.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000792:Angiography; D002292:Carcinoma, Renal Cell / Q000098:blood supply / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic; D004659:Enbucrilate; D005227:Fatty Acids; D005260:Female; D005500:Follow-Up Studies; D006417:Hematuria / Q000000981:diagnostic imaging / Q000628:therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000098:blood supply / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011409:Propylene Glycols; D012597:Sclerosing Solutions; D015996:Survival Rate; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D012597:Sclerosing Solutions; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution; D004659:Enbucrilate
Ergebnisse nach Katheterembolisation bei Nierenzellkarzinom.